AspenBio Pharma (APPY -13.8%) falls after pricing its previously announced secondary offering of...

|By:, SA News Editor

AspenBio Pharma (APPY -13.8%) falls after pricing its previously announced secondary offering of 1.5M shares at $2.10 each, a 15% discount to Wednesday's close. The diagnostic-product developer has a 7.7M share float outstanding at the beginning of November.